<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02900521</url>
  </required_header>
  <id_info>
    <org_study_id>REGISTRE AVC</org_study_id>
    <nct_id>NCT02900521</nct_id>
  </id_info>
  <brief_title>Population-based Brest Stroke Registry</brief_title>
  <acronym>BREST</acronym>
  <official_title>The Brest Registry of Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Santé publique France-InVS (Institut National de Veille sanitaire)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The registry is the main objective exhaustive list of cases validated stroke brain on a&#xD;
      geographical area defined to calculate an incidence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of Brest Stroke Registry is to regroup all confirmed cases of stroke over&#xD;
      a defined geographical zone in order to calculate an incidence.&#xD;
&#xD;
      There are three prospective medium-term goals:&#xD;
&#xD;
      - In respect with public health epidemiology:&#xD;
&#xD;
        1. To obtain incidence data and evaluate the regional and international divergences&#xD;
&#xD;
        2. To obtain the mortality data in short and long term. Since the onset of the registry, it&#xD;
           has been implemented a study on the mortality of stroke patients of Brest Registry. This&#xD;
           study has been realized independently for both types of stroke, i.e. ischemic and&#xD;
           hemorrhagic, with different caused mortality. This mortality was studied at medium-term&#xD;
           (≤ 28 days) as well as at long-term (&gt; 28 days). There will be a collaboration project&#xD;
           between Public Health Surveillance (InVS), Brest University Hospital and Rennes network&#xD;
           on all causes of death.&#xD;
&#xD;
        3. Pharmaco-epidemiology&#xD;
&#xD;
      In clinical terms, the registry offers an opportunity to do an inventory of all current&#xD;
      practices (diagnosis, therapies and the subsidiaries) and propose in this manner the best&#xD;
      management of stroke. This strategy is in line with the pilot programs deployed by the French&#xD;
      High Health Authority (HAS) for improvement of quality and safety of the health care. The&#xD;
      bleeding risk associated with anticoagulants and anti-platelet agents in people of Brest as&#xD;
      well as that of Dijon and Lille (in collaboration with their respective registry) will be&#xD;
      analyzed.&#xD;
&#xD;
      This study has gained a particular characteristic since 2012 with emerging new oral&#xD;
      anticoagulants (OAC) which have shown less associated bleeding risks compared with vitamin K&#xD;
      antagonists (randomized controlled trials).&#xD;
&#xD;
      •In terms of clinical research :&#xD;
&#xD;
        1. Study the impacted consequences of stroke by socio-economic characteristics of the&#xD;
           territories in the Pays de Brest&#xD;
&#xD;
        2. Identify short and long term clinical predictors of mortality in patients who have had a&#xD;
           hemorrhagic stroke.&#xD;
&#xD;
        3. To identify clinical predictors of mortality in the short and long-term patients with&#xD;
           ischemic stroke.&#xD;
&#xD;
        4. To identify genetic predictors of mortality and long-term recurrence of patients with&#xD;
           ischemic stroke&#xD;
&#xD;
        5. Identify stroke identification algorithm from existing databases&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Type of stroke (ischemic or haemorrhagic)</measure>
    <time_frame>Inclusion</time_frame>
    <description>The type of stroke ischemic or haemorrhagic will be collected from physician diagnostic</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient outcome</measure>
    <time_frame>Every year after the inclusion during 10 years</time_frame>
    <description>Patient outcome (mortality) wanted by mail from towns of birth</description>
  </secondary_outcome>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Cerebral (CVAs)</condition>
  <condition>Ischemic Cerebrovascular Accident</condition>
  <condition>Stroke</condition>
  <condition>Brain Ischemia</condition>
  <condition>Brain Hemorrhage</condition>
  <condition>Ischemic Stroke</condition>
  <condition>Hemorrhagic Stroke</condition>
  <condition>Cerebrovascular Disorders</condition>
  <condition>Transient Ischaemic Attack (TIA),</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Diagnostic validated for one of the following pathologies:&#xD;
&#xD;
          -  Ischemic stroke,&#xD;
&#xD;
          -  Non-traumatic intracranial hematoma&#xD;
&#xD;
          -  Cerebral venous thrombosis Diagnostic after December 31, 2007 Age &gt; 15 years on the&#xD;
             date of the diagnostic Patient domiciled at the time of the diagnostic in one of the&#xD;
             79 communes defined beforehand&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnostic validated for one of the following pathologies:&#xD;
&#xD;
          -  Ischemic stroke,&#xD;
&#xD;
          -  Non-traumatic intracranial hematoma&#xD;
&#xD;
          -  Cerebral venous thrombosis Diagnostic after December 31, 2007 Age &gt; 15 years on the&#xD;
             date of the diagnostic Patient domiciled at the time of the diagnostic in one of the&#xD;
             79 communes defined beforehand&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age ≤ 15 years&#xD;
&#xD;
          -  Validated diagnosis (see below, § 4.2.2) of aneurysmal subarachnoid hemorrhage&#xD;
             cerebrovascular&#xD;
&#xD;
          -  Diagnosis made before 1 January 2008&#xD;
&#xD;
          -  Unconfirmed diagnosis&#xD;
&#xD;
          -  Patient domiciled outside the previously defined area of residence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serge TIMSIT</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU La Cavale Blanche - BREST - FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Serge TIMSIT</last_name>
    <phone>+3329847620</phone>
    <email>serge.timsit@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge TIMSIT</last_name>
      <phone>+33298347620</phone>
      <email>serge.timsit@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Francois ROUHART</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irina VIAKHIREVA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François Mathias MERRIEN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe GOAS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>August 22, 2016</study_first_submitted>
  <study_first_submitted_qc>September 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2016</study_first_posted>
  <last_update_submitted>September 9, 2016</last_update_submitted>
  <last_update_submitted_qc>September 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hemorrhagic Stroke</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

